ethica CRO

EUIPO EUIPO 2024 Application published

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ethica CRO was filed as Figurative mark on 04/25/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application published".

Logodesign (Wiener Klassifikation)

#Vertical lines or bands #More than three lines

Trademark Details Last update: October 15, 2024

Trademark form Figurative mark
File reference 019019260
Application date April 25, 2024
Publication date August 1, 2024

Trademark owner

3551 Saint-Charles Blvd., Suite 501
H9H 3C4 Kirkland, QC
CA

Trademark representatives

goods and services

35 Commercial assistance services in respect of contract research services for clinical trials, namely recruiting investigators, providing strategies for recruitment of participants, screening participants; administrative management services for clinical trial, namely: pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, closeout visits, project tracking and monitoring reports, administration of investigator grants, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; clinical trial management services, namely site and study-specific subject recruitment strategies and programs; clinical trial supplies management services, namely: customized drug packaging and labelling, randomization (central and site administered) and study supply distribution, developing and managing distribution and storage logistics for all clinical supplies (study drugs and devices, case report forms, study binders, all study related documentation); business operation in respect of medical writing services; providing statistical analyses and reporting
36 Negotiation of investigator grants
39 Labelling, packaging, distribution of clinical trial materials
41 Conducting investigator meetings in respect of contract research services for clinical trials; clinical trial management training services, namely study-specific clinical personnel training programs for investigators and coordinators, investigator meetings
42 Contract research services for clinical trials, namely conducting an ethical review of projects to protect the rights and welfare of research participants; contract research services for clinical trials, namely developing study protocols, designing case report forms; developing complete databases in accordance with strict guidelines, tracking of technical study parameters; development of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries, adverse events; developing and managing randomization logistics, namely randomization envelopes, customized blindbreakable drug labelling, code break management and reports, manufacturing of subject- and protocol specific kits using bulk oral and topical medications; drafting clinical study protocols, statistical analysis plans, full integrated clinical research reports, publications, abstracts and manuscripts; clinical trial management services, namely contingency strategies and solutions to address specific project challenges, development of all study related documents and materials, namely study protocols, amendments, case report forms (paper or electronic), informed consent forms, study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints, study newsletters (paper or electronic); managing all aspects of study drug reconciliation and inventory and distribution reports; management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries, adverse events; development and maintenance of tracking software for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries, adverse events

ID: 11019019260